Warner-Lambert’s Cognex (tacrine)
Executive Summary
NDA for the Alzheimer's disease treatment filed with FDA, Warner-Lambert reported June 4. The NDA contains data from one clinical trial conducted with the National Institute on Aging at 16 U.S. sites, and another study conducted in England by Shire Pharmaceuticals.